Recalls for Cubist Pharmaceuticals

CUBICIN (daptomycin for injection) 500 mg in 10 mL Single Use Vials: Recall - Foreign Particulate Matter
08/09/2014 Medical Recall

Administration of particulate matter poses a potential safety risk to patients such as a thromboembolism or a life-threatening pulmonary embolism.

  • Company:
    Cubist Pharmaceuticals